NPI: 1033172135 · RIVERSIDE, CA 92501 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/10/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/10/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 38,694 | $1.77M |
| 2019 | 41,825 | $1.90M |
| 2020 | 33,290 | $1.58M |
| 2021 | 29,976 | $1.46M |
| 2022 | 28,475 | $1.37M |
| 2023 | 32,455 | $1.68M |
| 2024 | 20,937 | $1.99M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 74,991 | 6,442 | $11.42M |
| A4657 | Syringe, with or without needle, each | 6,049 | 3,002 | $246K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 58,182 | 4,669 | $44K |
| J1756 | Injection, iron sucrose, 1 mg | 18,571 | 4,559 | $11K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,203 | 693 | $9K |
| J2501 | Injection, paricalcitol, 1 mcg | 39,575 | 3,200 | $5K |
| 0250 | 9,721 | 556 | $5K | |
| 90677 | 12 | 12 | $1K | |
| 82728 | 1,660 | 1,549 | $826.45 | |
| 90661 | 20 | 20 | $662.93 | |
| J1270 | Injection, doxercalciferol, 1 mcg | 3,442 | 287 | $596.52 |
| 83970 | 2,200 | 2,075 | $344.90 | |
| 90674 | 132 | 131 | $173.13 | |
| 85041 | 2,515 | 2,395 | $82.60 | |
| 83550 | 1,458 | 1,355 | $68.20 | |
| 83540 | 1,676 | 1,558 | $62.26 | |
| 85048 | 2,428 | 2,318 | $31.44 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 628 | 519 | $27.99 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 917 | 873 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 123 | 121 | $0.00 |
| 86706 | 27 | 19 | $0.00 | |
| 90747 | 15 | 15 | $0.00 | |
| 90662 | 90 | 88 | $0.00 | |
| 82108 | 17 | 12 | $0.00 |